Last updated: March 27, 2023
Sponsor: Far Eastern Memorial Hospital
Overall Status: Active - Recruiting
Phase
4
Condition
Interstitial Cystitis
Treatment
N/AClinical Study ID
NCT03251300
106001-F
Ages > 20 Female
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- OAB symptoms for at least one month
- >20 years
Exclusion
Exclusion Criteria:
- Allergy to mirabegron, urinary tract infections, unstable hypertension
Study Design
Total Participants: 120
Study Start date:
August 01, 2017
Estimated Completion Date:
December 31, 2024
Study Description
Connect with a study center
Far Eastern Memorial Hospital
Banqiao, New Taipei 22050
TaiwanActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.